Monograph: Taurine

Date: 2019-06-03

NHPID name

Taurine ( O'Neil et al. 2012 )

Proper name(s)

2-Aminoethanesulfonic acid ( Unavailable )

Common name(s)

Taurine ( Unavailable )

Source material

• L-Arginine taurinate (Unavailable)
• Synthetic (Unavailable)
• Taurine (Unavailable)
• Taurine ethyl ester (Unavailable)

Route Of administration

Oral

Dosage form(s)

The acceptable pharmaceutical dosage forms suited to oral administration include, but are not limited to, chewables (e.g. gummies, tablets), caplets, capsules, strips, lozenges, powders or liquids where the dose is measured in drops, teaspoons or tablespoons. This labelling standard is not intended to include foods or food-like dosage forms such as bars, chewing gums or beverages.

Use(s) or purpose(s)

Statement(s) to the effect of:

Helps to support cardiovascular function.  (Allard et al. 2006, Zhang et al. 2004, Baum and Weiss 2001, Azuma 1994, Azuma et al. 1992, Fujita et al. 1987, Azuma et al. 1983)

Dose(s)

Adults:

Duration of use

No statement is required

Risk information

Statement(s) to the effect of:

Caution(s) and Warning(s): Consult a health care practitioner/health care provider/health care professional/doctor/physician prior to use if you are pregnant or breastfeeding.  (Lopez Ramon et al. 2007, Seghieri et al. 2007) Contraindication(s): No statement is required Known Adverse Reaction(s): No statement is required

Non-medicinal ingredients

Must be chosen from the current Natural health products ingredients database and must meet the limitations outlined in the database.

Specifications

• The finished product specifications must be established in accordance with the requirements described in the NHPD Quality of natural health products guide.
• The medicinal ingredient must comply with the requirements outlined in the Natural health products ingredient database (NHPID).